Skip Navigation LinksHome > Press

For Immediate Release
October 22, 2014
AABB Public Relations Department
AABB and AATM Form Collaborative Partnership to Promote Safe Blood and Cellular Therapy Practices in Asian Countries

Bethesda, Md. - The leadership of AABB and the Asia Association for Transfusion Medicine, or AATM, signed on September 13, 2014, a memorandum of understanding, or MoU, aimed at promoting common goals in transfusion medicine and cellular therapies. The exclusive collaboration — headed by a joint leadership team — will increase adoption and dissemination of blood and cellular therapies standards in Asia as well as accreditation programs in these disciplines. Among the joint efforts, the team intends to offer online education and training programs and will consider presenting wet workshops to advance patient and donor care and safety. The leadership team also may provide additional educational programs, including fellowships for young professionals.

“As the emphasis on global medical practices intensifies, we look forward to establishing a strong inter-organizational relationship with the Asian Association for Transfusion Medicine that will help spread the adoption of standards for transfusion medicine and cellular therapies, as well as sound accreditation practices, in their member countries,” said Miriam A. Markowitz, AABB CEO.

“This collaboration will act as a needed enhancement to transfusion medicine to ensure safety for all patients,” said AATM President Farrukh Hasan, MD. “There is growing interest in transfusion medicine, and this MoU is a wonderful step forward.”

The Secretary General of AATM, Nabajyoti Choudhury, MD, added, “This MoU will open a new opportunity for collaboration amongst transfusion medicine professionals from Asia. Such an agreement addresses the need for safe blood components and products across our region.”

The term of the MoU is three years and may extend to other areas of mutual interest and benefit.

About AABB

AABB is an international, not-for-profit association representing individuals and institutions involved in the field of transfusion medicine, cellular therapies, and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership consists of nearly 2,000 institutions and 8,000 individuals, including physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. Members are located in more than 80 countries. For more information, visit

About AATM

The Asian Association of Transfusion Medicine is a manifestation of the determination of leading specialists in transfusion medicine from Asian countries to work together towards finding solutions for their common problems in the spirit of friendship, trust and understanding and to create an order based on mutual respect, equality and shared benefits. AATM has members in sixteen countries and official chapters in eleven countries throughout Asia. The primary objective of the association is to accelerate the scientific progress and common standard in blood transfusion services in member states in the Asian region.

# # #